BSEInsider Trading / SAST4d ago · 26 Aug 2026, 04:46 pm
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 26, 2026 for Union (Mauritius) Holdings Ltd
Aster DM Quality Care Ltd · 540975
✦ AI SummaryPledge
Aster DM Quality Care Ltd has received a disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, regarding the creation of an indirect encumbrance over its shares by Union (Mauritius) Holdings Ltd.
Analysis Scores
Earnings Impact2/10
Growth Catalyst2/10
Governance Concern3/10
Regulatory Risk2/10
Balance Sheet Risk4/10
Liquidity Impact5/10
Market Sentiment4/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Aster DM Quality Care Ltd - 540975 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
Attachments (1)
📄pdf
Download →
749265CF_2FEA_4C49_97AD_62BDDD148259_164609.pdf
View document text
Date: August 26, 2026
BSE Limited The National Stock Exchange of India Limited,
Phiroze Jeejeebhoy Towers Exchange Plaza, Bandra Kurla Complex,
Dalal Street, Fort Bandra (East), Mumbai: 400051
Mumbai 400 001 Tel: 022-26598235/ 36/ 452
Fax: (022) 2272 2131 / 2037 / 2061 / 41 Fax: 022-26598237/ 38
Email: corp.relations@bseindia.com Email: takeover@nse.co.in
The Board of Directors,
Aster DM Quality Care Limited (Formerly Aster DM Healthcare Limited)
No. 7-1-450/20, Plot No. 04, Mythri Vihar,
Ameerpet, Hyderabad, Telangana, 500038
Dear Sir/Madam,
Re: Disclosure under Regulation 31(1) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 (“Takeover Code”)
Please find enclosed the disclosure under Regulation 31(1) of the Takeover Code with respect to creation of an indirect encumbrance over shares of
Aster DM Quality Care Limited (Formerly Aster DM Healthcare Limited) (the “Target Company”).
For and on behalf of Union (Mauritius) Holdings Limited
Name: Dr. Azad Moopen Mandayapurath
Authorized Signatory
Date: 26 August 2026
Place: Dubai
Disclosures under Regulation 31(1) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011
ANNEXURE- 1
Disclosure by the Promoter(s) to the stock exchanges and to the Target Company for creation of encumbrance in terms of Regulation
31(1) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011
Name of the Target Company (TC): Aster DM Quality Care Limited (Formerly Aster DM Healthcare Limited)
Names of the stock exchanges where the National Stock Exchange of India Limited and BSE Limited
shares of the target company are listed:
Date of reporting: August 26, 2026
Name of the promoter or PAC on whose Union (Mauritius) Holdings Limited
shares encumbrance has been
created/released/invoked:
Details of the creation/invocation/release of encumbrance: Creation of indirect encumbrance
Name of Promoter Promoter holding Details of events pertaining to encumbrance (3) Post event holding of
the holding in the already encumbered shares
promoter target company encumbered (2) {creation [(2)+(3)] /
(s) or (1) release [(2)-(3)] //
PACs invocation [(1)-(3)]]
with him
Number % of Number % of Type of Date of Type of Reasons for Number % of Name of Number % of total
total total event creation/ encumbra encumbrance share the entity share
share share (creation / release/ nce capital in whose capital
capita capital release / invocation (pledge/ favor
l invocation) of lien/ non shares
encumbra disposal encumbe
nce undertaki red
others)
Union 1,99,80, 2.29 1,99,80,52.29% Creation of August Pledge Creation of N.A. N.A. DB 1,99,80,5 2.29%
(Mauritiu 522 % 22 indirect 24, 2026 pledge over Trustees 22[Please
s) encumbran 100% shares (Hong see the
Holdings [Please ce of UMHL by Kong) note
Limited see the Dr. Azad Limited below*]
(“UMHL note Moopen acting as
”) below*] Mandayapur Common
ath, Ms. Offshore
Alisha Security
Moopen, Agent
Ms. Naseera for
Azad, Ms. Barclays
Zeba Azad Bank
Moopen and PLC and
Ms. Ziham J.P.
Moopen as Morgan
collateral in Chase
favour of DB Bank,
Trustees N.A.,
(Hong London
Kong) Branch
Limited to (“Lende
secure an rs”)
existing loan
facility of
160,000,000
(“Facility
A”) ** and
50,000,000
(“Facility
B”) availed
by Union
Investment
Pvt Limited
(“UIPL”)
from
Barclays
Bank PLC
and J.P.
Morgan
Chase Bank,
N.A.,
London
Branch.
*Note: While no new direct encumbrance has been created by UMHL over its shareholding in the Target Company for Facility A and Facility B,
existing encumbrances in relation to previous indebtedness continue, which will be immediately released upon completion of conditions stipulated
by the Lenders.
**Facility A is an existing indebtedness of UIPL where the loan amount has now been increased from USD 145 Million to USD 160 Million
Signature of the Authorized Signatory
For Union (Mauritius) Holdings Limited
Name: Dr. Azad Moopen Mandayapurath
Place: Dubai
Date: 26 August 2026
Annexure – II
Disclosure of reasons for encumbrance
Name of listed company Aster DM Quality Care Limited (Formerly Aster DM Healthcare Limited)
(“Target Company”)
Name of the recognised stock exchanges where the shares of the National Stock Exchange of India Limited and BSE Limited
company are listed
Name of the promoter(s)/PACs whose shares have been Union (Mauritius) Holdings Limited (“UMHL”)
encumbered
Total promoter shareholding in the listed No. of shares - 1,99,80,522
company
% of total share capital 2.29%
Encumbered shares as a % of promoter shareholding As on date, the promoter has not created any new encumbrance over its
shareholding in the Target Company to secure the term loan facility of USD
160,000,000 (“Facility A”) and the term loan facility of USD 50,000,000
(“Facility B”) each availed by UIPL from Barclays Bank PLC and J.P. Morgan
Chase Bank, N.A., London Branch (“Lenders”). However, do note that existing
encumbrance in relation to previous indebtedness continues, which will be
immediately released upon completion of conditions stipulated by the lenders.
100% shares of UMHL have been pledged by Dr. Azad Moopen Mandayapurath,
Ms. Alisha Moopen, Ms. Naseera Azad, Ms. Zeba Azad Moopen and Ms. Ziham
Moopen in favour of DB Trustees (Hong Kong) Limited to secure the Facility A
and Facility B.
Whether encumbered share is 50% or more of promoter Not Applicable [Please refer to note above]
shareholding
Whether encumbered share is 20% or more of total share capital Not Applicable [Please refer to note above]
Details of all the existing events/ agreements pertaining to encumbrance
Type of encumbrance (pledge, lien, negative lien, non-disposal Pledge
undertaking etc. or any other covenant, transaction, condition or
arrangement in the nature of encumbrance) (Date of creation of encumbrance: August 24, 2026)
No. of shares encumbered Nil [Please refer to note above]
% of shares encumbered Nil [Please refer to note above]
Specific details about Name of the entity in whose favour shares DB Trustees (Hong Kong) Limited
the encumbrance encumbered (X)
Whether the entity X is a scheduled commercial No
bank, public financial institution, NBFC or
housing finance company? If No, provide the DB Trustees (Hong Kong) Limited is the Common Offshore Security
nature of the business of the entity. Agent for Barclays Bank PLC and J.P. Morgan Chase Bank, N.A.,
London Branch
Names of all other entities in the agreement Listed company and its group companies (if any) – Not Applicable
Other entities (if any) (parties to share pledge agreement) –
1. Union (Mauritius) Holdings Limited as Borrower
2. Dr. Azad Moopen Mandayapurath, Ms. Alisha Moopen, Ms.
Naseera Azad, Ms. Zeba Azad Moopen and Ms. Ziham Moopen as
Pledgors
3. DB Trustees (Hong Kong) Limited as the Common Offshore
Security Agent
Whether the encumbrance is relating to any debt No
instruments viz. debenture, commercial paper,
certificate of deposit etc.? If yes, provide details
about the instrument, including credit rating
Security Cover / Asset Value of shares on the date of event / agreement Not Applicable [Please refer to note above]
Cover (A)
Amount involved (against which shares have been USD 160,000,000 and USD 50,000,000
encumbered) (B)
Ratio of A / B Not Applicable [Please refer to note above]
End use of Borrowed amount to be utilized for what purpose • Facility A is an existing indebtedness of UIPL where the loan
amount has now been increased from USD 145 Million to USD 160
Money (a) Personal use by promoters and PACs Million. The additional indebtedness of USD 15 Million will be
utilized towards general corporate purposes of the Borrower
(b) For the benefit of listed company overseas.
Provide details including amount, • The term loan facility of USD 50,000,000 is proposed to be utilized
by UIPL for extending an inter-company loan to UMHL and other
purpose of raising money by listed company,
purposes as may be permitted by the Lenders.
schedule for utilization of amount, repayment
schedule etc.
(a) Any other reason (please s
[Showing first 8,000 characters — download PDF for full document]